A. Mander

发表

Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD.

R. Buhl, O. Kornmann, K. Beeh, 2003, Chest.

Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.

M. Moustaki, A. Postle, J. Warner, 1999, American journal of respiratory cell and molecular biology.

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

E. Bonifacio, M. Knip, D. Dunger, 2022, Trials.

Protein kinase-zeta interacts with munc18c: role in GLUT4 trafficking.

C. Hodgkinson, G. J. Sale, A. Mander, 2005, Diabetologia.

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time

D. Dearnaley, T. Tjelle, P. Bass, 2012, Cancer Immunology, Immunotherapy.

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes

S. Halford, U. Şahin, D. Jodrell, 2016, Clinical Cancer Research.

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes Running Title: Anti-CEA DNA Fusion Vaccination

S. Halford, U. Şahin, D. Jodrell, 2016 .

Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.

W. Bernhard, A. Postle, J. Warner, 2002, American journal of respiratory cell and molecular biology.

DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer.

D. Dearnaley, T. Tjelle, C. Ottensmeier, 2009, Human gene therapy.

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study

M. Jenner, C. Ottensmeier, F. Stevenson, 2015, Cancer Immunology, Immunotherapy.

Knock‐down of LAR protein tyrosine phosphatase induces insulin resistance

C. Hodgkinson, G. J. Sale, A. Mander, 2005, FEBS letters.

DNA fusion vaccines enter the clinic

C. Ottensmeier, F. Stevenson, A. Mander, 2011, Cancer Immunology, Immunotherapy.

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

A. Mackensen, Tania T. Køllgaard, C. Gouttefangeas, 2007, Cancer Immunology, Immunotherapy.

Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines

Ferdousi Chowdhury, C. Ottensmeier, A. Mander, 2009, Cancer Immunology, Immunotherapy.

Response definition criteria for ELISPOT assays revisited

Cedrik M. Britten, Z. Moodie, L. Price, 2010, Cancer Immunology, Immunotherapy.

Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

C. Gouttefangeas, A. Mander, M. J. P. Welters, 2010, Cancer Immunology, Immunotherapy.

Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking.

C. Hodgkinson, G. J. Sale, A. Mander, 2005, The Biochemical journal.

Hepatic and plasma phospholipid molecular species compositions in the pregnant guinea pig: Effect of chronic ethanol consumption

A. Postle, G. Burdge, A. Mander, 1996 .

Protein kinase-ζ interacts with munc18c: role in GLUT4 trafficking

C. Hodgkinson, G. J. Sale, A. Mander, 2005, Diabetologia.

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time

T. Tjelle, C. Ottensmeier, A. Mander, 2012, Cancer Immunology, Immunotherapy.

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes

U. Şahin, C. Ottensmeier, T. Weinschenk, 2016 .